Dantrolene for muscle rigidity in progressive supranuclear palsy

Area of Science:

• Neurology
• Pharmacology

Background:

• Progressive supranuclear palsy (PSP) presents significant motor challenges, including postural instability, bradykinesia, and rigidity.
• Effective pain management strategies for neurodegenerative diseases remain limited, with a scarcity of research in this area.

Observation:

• A case report details a patient experiencing refractory dystonia and muscle rigidity associated with PSP.
• The patient's symptoms were unresponsive to conventional non-pharmacological and pharmacological treatments.

Findings:

• Dantrolene administration led to successful relief of widespread dystonia and muscle rigidity.
• This represents the first reported instance of dantrolene use for refractory muscle rigidity pain in a neurodegenerative condition.

Implications:

• Dantrolene shows promise as a therapeutic option for managing severe, refractory muscle rigidity and dystonia in PSP.
• Further research into dantrolene's efficacy for pain management in neurodegenerative disorders is warranted.